NASDAQ
13 hours, 44 minutes ago 
WW
Ww International, INC
8-K: WW International Faces Delisting from Nasdaq Amid Chapter 11 Proceedings
WW International (Weight Watchers) receives notice of delisting from Nasdaq following the commencement of voluntary prepackaged Chapter 11 cases.
Worse than expected
 
NASDAQ
3 days, 0 hours ago 
WW
Ww International, INC
8-K: WW International Files for Chapter 11 to Restructure Debt, Aims for Quick Exit
WW International, Inc. initiates a pre-packaged Chapter 11 reorganization to eliminate $1.15 billion in debt and enhance its financial flexibility.
NASDAQ
3 days, 14 hours ago 
WW
Ww International, INC
10-Q: WW International Faces Debt Restructuring Amidst Financial Challenges
WW International is in discussions to restructure its debt and anticipates a prepackaged bankruptcy filing due to financial difficulties and an expected event of default.
Worse than expected
 
NASDAQ
3 days, 14 hours ago 
WW
Ww International, INC
8-K: WW International Announces Q1 2025 Results, Clinical Subscriptions Surge Amid Debt Restructuring
WW International reports a 9.7% revenue decrease in Q1 2025, but sees a 57.1% increase in clinical subscription revenues and is engaged in discussions for a plan of reorganization to significantly reduce debt.
Worse than expected
 
NASDAQ
18 days, 14 hours ago 
WW
Ww International, INC
DEF: WW International Sets Date for 2025 Annual Shareholder Meeting, Outlines Key Proposals
WW International announces its 2025 Annual Meeting of Shareholders to be held virtually on June 6, 2025, featuring proposals for director elections, auditor ratification, and executive compensation approval.
NASDAQ
21 days, 14 hours ago 
WW
Ww International, INC
Form 4: WW International Executive Michael Amsel Awarded Restricted Stock Units
Chief Marketing Officer Michael Amsel receives 524,109 restricted stock units in WW International, Inc.
NASDAQ
39 days, 14 hours ago 
WW
Ww International, INC
Form 4: WW International CEO Tara Comonte Reports Stock Transactions
Tara Comonte, President and CEO of WW International, reports the acquisition and disposal of common stock and restricted stock units on March 27, 2025.
NASDAQ
49 days, 14 hours ago 
WW
Ww International, INC
8-K: WW International Faces Nasdaq Delisting Notice After Share Price Drops Below $1.00
WW International (WeightWatchers) received a notice from Nasdaq for failing to maintain a minimum share price of $1.00, putting its listing at risk.
Worse than expected
 
NASDAQ
67 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International CEO Tara Comonte Reports Stock Transactions
Tara Comonte, President and CEO of WW International, reports the acquisition and disposal of common stock and restricted stock units on February 27, 2025.
NASDAQ
70 days, 22 hours ago 
WW
Ww International, INC
10-K: WW International Reports Fiscal Year 2024 Results: Transformation Efforts Continue Amidst Market Challenges
WW International faces revenue decline due to shifts in consumer behavior and increased competition, but focuses on strategic initiatives and cost management.
Worse than expected
 
WW 
Ww International, INC 
NASDAQ

8-K: WW International Faces Delisting from Nasdaq Amid Chapter 11 Proceedings

Sentiment:
 8-K Filing
 9 May 2025 5:03 PM

WW International (Weight Watchers) receives notice of delisting from Nasdaq following the commencement of voluntary prepackaged Chapter 11 cases.

Worse than expected
  The company received a delisting notice from Nasdaq.  The company has commenced voluntary prepackaged cases under chapter 11 of title 11 of the United States Code.  Trading of WW International's common stock is expected to be suspended on May 16, 2025. 

Summary
  • WW International, Inc. received a delisting notice from Nasdaq on May 9, 2025, due to the company's commencement of voluntary prepackaged Chapter 11 cases on May 6, 2025.
  • Nasdaq will suspend trading of WW International's common stock on May 16, 2025, and file a Form 25-NSE to effect the delisting.
  • The company intends to appeal the delisting determination and seek to list the new common equity of the reorganized company on Nasdaq or another national stock exchange after emerging from Chapter 11.
  • Following the trading suspension, the company anticipates its common stock will commence trading on the Pink Current Market, operated by OTC Markets Group.
  • The company states that the transition to the over-the-counter market is not expected to affect its business operations, but there is no assurance that trading will commence or continue, or that an efficient trading market will exist.
Sentiment

Score: 2

Explanation: The sentiment is negative due to the delisting notice and Chapter 11 proceedings, indicating significant financial distress and uncertainty about the company's future.

Highlights
  • WW International received a delisting notice from Nasdaq due to Chapter 11 proceedings.
  • Trading of WW International's common stock is expected to be suspended on May 16, 2025.
  • The company plans to appeal the delisting and relist on Nasdaq or another exchange post-reorganization.
  • The company anticipates trading on the Pink Current Market after suspension.
  • The company acknowledges uncertainty regarding the trading of its common stock on the over-the-counter market.
Positives
  • The company intends to appeal the delisting decision.
  • The company plans to relist on Nasdaq or another national exchange after emerging from Chapter 11.
  • The company anticipates its common stock will commence trading on the Pink Current Market, operated by OTC Markets Group.
  • The company states that the transition to the over-the-counter market is not expected to affect its business operations.
Negatives
  • WW International received a delisting notice from Nasdaq.
  • Trading of WW International's common stock is expected to be suspended on May 16, 2025.
  • The company has commenced voluntary prepackaged cases under chapter 11 of title 11 of the United States Code.
  • There is no assurance that trading will commence or continue on the over-the-counter market, or that an efficient trading market will exist.
Risks
  • The company faces risks and uncertainties related to the Chapter 11 Cases, including obtaining Bankruptcy Court approval and confirmation of the plan of reorganization.
  • The Chapter 11 Cases could have adverse effects on the company's liquidity and ability to pursue its business strategies.
  • There is a risk of cancellation of the company's common stock in the Chapter 11 Cases.
  • There is uncertainty regarding the company's ability to retain key personnel and management.
  • The company's members might lose confidence in the company's ability to reorganize its capital structure successfully.
  • There are continuing risks associated with the company's ability to achieve its goals and continue as a going concern.
Future Outlook

The company intends to seek to list the new common equity of the reorganized company on Nasdaq or another national stock exchange as soon as possible after emerging from Chapter 11. The company anticipates that following suspension from trading, its common stock will commence trading on the Pink Current Market, operated by OTC Markets Group.

Industry Context

The announcement reflects the challenges faced by companies in the weight management industry, particularly those with significant debt burdens, as they navigate evolving consumer preferences and increased competition from digital health solutions.

Stakeholder Impact
  • Shareholders face the risk of significant dilution or cancellation of their existing shares.
  • Employees face uncertainty regarding their job security and the company's future.
  • Customers may experience disruptions in service or changes to the company's offerings.
  • Suppliers and creditors face the risk of non-payment or renegotiation of contracts.
Next Steps
  • The company intends to appeal Nasdaq's delisting determination.
  • The company will seek to list the new common equity of the reorganized company on Nasdaq or another national stock exchange after emerging from Chapter 11.
  • The company anticipates its common stock will commence trading on the Pink Current Market.
Legal Proceedings
  • The company has commenced voluntary prepackaged cases under chapter 11 of title 11 of the United States Code.
Key Dates
  • May 6, 2025: WW International commenced voluntary prepackaged cases under chapter 11.
  • May 9, 2025: WW International received a delisting notice from Nasdaq.
  • May 16, 2025: Nasdaq will suspend trading of WW International's common stock.
Keywords
delisting, Nasdaq, Chapter 11, bankruptcy, WW International, trading suspension, reorganization, common stock, OTC Markets, Pink Current Market
WW 
Ww International, INC 
NASDAQ
Sector: TBD
 
Filings with Classifications
Worse than expected
9 May 2025 5:03 PM
8-K Filing
  • The company received a delisting notice from Nasdaq.
  • The company has commenced voluntary prepackaged cases under chapter 11 of title 11 of the United States Code.
  • Trading of WW International's common stock is expected to be suspended on May 16, 2025.
Worse than expected
6 May 2025 4:13 PM
Quarterly Report
  • The company's financial results were worse than expected due to declining revenues and increasing losses.
  • The company's leverage ratio was worse than required by its debt covenants, leading to an expected event of default.
  • The company's outlook is worse than expected due to the anticipation of a bankruptcy filing.
Worse than expected
6 May 2025 4:03 PM
Earnings Release
  • Overall revenues decreased by 9.7% year-over-year, indicating a decline in the core business.
  • Total subscribers decreased by 14.2% year-over-year, suggesting challenges in retaining and attracting customers.
  • The company is planning a prepackaged filing under Chapter 11 of the U.S. Bankruptcy Code, indicating financial distress.
Worse than expected
21 March 2025 4:05 PM
8-K Filing
  • WW International received a notice from Nasdaq for failing to maintain a minimum share price of $1.00, which is worse than expected.
Worse than expected
28 February 2025 7:14 AM
Annual Results
  • The company's revenue decreased by 11.6% compared to the previous year.
  • The company recorded a net loss of $345.7 million, a significant increase from the net loss of $112.3 million in the previous year.
  • The company's operating loss was $236.2 million, compared to an operating income of $22.3 million in the previous year.
Worse than expected
27 February 2025 4:01 PM
Earnings Release
  • Overall subscriber numbers and total revenues decreased in both Q4 and full year 2024.
  • Digital and Workshops + Digital businesses experienced declines in subscribers and paid weeks.
  • The company reported a significant operating loss for the full year, driven by non-cash impairment charges.
Worse than expected
3 February 2025 4:15 PM
8-K Filing
  • The company needed to draw down the remaining amount of its revolving credit facility, which may indicate financial strain.
Worse than expected
6 November 2024 4:03 PM
Quarterly Report
  • The company's Q3 2024 results were worse than expected due to a significant net loss, a decline in revenue, and substantial impairment charges.
  • The company's net loss for the first nine months of 2024 was significantly worse than the same period in 2023 due to a large impairment charge.
Worse than expected
6 November 2024 7:05 AM
Quarterly Report
  • The company's revenue and overall subscriber numbers were down compared to the prior year, indicating worse than expected results.
Worse than expected
1 August 2024 7:13 AM
Quarterly Report
  • The company's revenue declined by 10.9% in the second quarter and 12.8% for the first six months of 2024, indicating worse than expected performance.
  • The company recorded a significant net loss of $324.6 million for the first six months of 2024, primarily due to a large impairment charge, which is worse than expected.
Worse than expected
1 August 2024 7:05 AM
Quarterly Report
  • The company's revenue decreased by 10.9% year-over-year, indicating worse than expected performance.
  • The company's net income decreased by 54.2% year-over-year, indicating worse than expected performance.
  • The company's total end of period subscribers decreased by 6.1% year-over-year, indicating worse than expected performance.
Worse than expected
24 May 2024 5:15 PM
Amendment to 8-K Filing
  • The proposal to adopt a majority voting standard for uncontested director elections was not approved by shareholders, which is a negative outcome for the company's governance structure.
  • The initial voting results were erroneous, requiring a correction, which reflects poorly on the company's internal processes.
Worse than expected
9 May 2024 5:39 PM
Quarterly Report Amendment
  • The company's net loss of $347.9 million is significantly worse than the $118.7 million loss in the same period last year.
  • The company's revenue decreased by 14.6%, indicating a worse performance compared to the prior year.
  • The company's operating loss of $269.3 million is significantly worse than the $28.6 million loss in the prior year.
Worse than expected
9 May 2024 4:30 PM
Quarterly Report Amendment
  • The company's revenue decreased by 14.6% year-over-year, indicating a worse performance than expected.
  • The company reported a significant operating loss of $269.3 million, primarily due to non-cash impairment charges, which is worse than expected.
  • The company's total end of period subscribers decreased by 0.5% year-over-year, indicating a worse performance than expected.
Worse than expected
2 May 2024 4:09 PM
Quarterly Report
  • The company's net loss of $347.9 million is significantly worse than the $118.7 million loss in the same quarter last year.
  • The company's revenue decreased by 14.6%, indicating a decline in business performance.
  • The company incurred a $258 million impairment charge on franchise rights, further impacting the financial results.
Worse than expected
2 May 2024 4:05 PM
Quarterly Report
  • The company reported a significant operating loss of $269.3 million, primarily due to non-cash impairment charges, which is worse than expected.
  • Subscription revenues decreased by 3.7% on a constant currency basis, indicating a decline in core business performance.
  • Other revenues declined dramatically by 92.0% on a constant currency basis, which is a significant negative impact.
Better than expected
14 March 2024 4:41 PM
Regulation FD Disclosure
  • The company is on track to exceed its previously provided guidance for clinical subscribers, indicating better than expected performance.
Worse than expected
28 February 2024 4:29 PM
Annual Results
  • The company's revenue decreased by 14.5% year-over-year, indicating worse than expected performance.
  • The company's gross profit decreased by 14.8% year-over-year, indicating worse than expected performance.
  • The company's operating income margin decreased by 4.6% year-over-year, indicating worse than expected performance.
Worse than expected
28 February 2024 4:06 PM
Quarterly Report
  • The company's revenue decreased by 7.6% in Q4 2023 and 14.5% for the full year 2023, indicating worse than expected performance.
  • The company reported a net loss of $88.1 million in Q4 2023 and $112.3 million for the full year 2023, which is worse than the prior year.

Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.